Vincenzo Scattoni

Request an appointment

Specialty:

Urology Adult Urology Genitourinary Oncology Oncology

Profession:

Urologist

Location:

Department of Urology I @ Ospedale San Raffaele

Languages:

Request an appointment

Biography

Dr. Vincenzo Scattoni is the coordinator of the area of assistance in the Department of Urology at the IRCCS Ospedale San Raffaele in Milan under the supervision of Professor Francesco Montorsi.

After graduating from the Faculty of Medicine and Surgery in 1990 at the University of Milan, he specialized in urology at the same institute in 1995. During his educational career, he passes various internships abroad, in particular, in the departments of urology in Erlangen, Homburg, Saarland, Mainz, Wuppertal (Germany) and New York (USA). In 2001, he received a second specialization in pediatric surgery at the University of Milan.

Dr. Scattoni has performed more than 5,000 interventions in all areas of urology as the first surgeon. In particular, he has extensive experience in all interventions related to prostate pathology (benign and malignant): from laser surgery of prostatic hypertrophy (holmium laser – HOLEP) to robotic surgery (Da Vinci system) for prostate cancer. Performs laparoscopy for malignant neoplasms of the kidneys, as well as for endoscopic treatment of kidney stones and ureters by laser lithotripsy (RIRS).

The main research interest of Dr. Vincenzo Scattoni concerns the diagnosis of prostate cancer and diagnosis by prostate biopsy (systematic, saturated and fusion method). He is currently researching strategies for the diagnosis and treatment of BPH and robotic surgery for prostate cancer.

Education

University of Milan,
Degree in Medicine and Surgery, 1990

University of Milan,
Specialization in urology, 1995

University of Milan,
Specialization in pediatric surgery, 2001

Do you need an appointment?

Request an appointment

Publications

The total number of his scientific works is 654 (publications and abstracts), he has written 6 books and 13 chapters in books. His Hirsch index is 42.

Since 2002, he has been an official reviewer of the following scientific journals: Journal of Urology, European Urology, British Journal of Urology International, Lancet, Cancer Detection and Prevention, Urologia Internationalis, Brazilian Journal of Urology, Prostate Cancer and Prostatic Diseases, Medical Science Monitor (International Medical Journal for Experimental and Clinical Research). Since 2004 he has been a member of the steering committee of SIEUN (Italian Society of Urological and Nephrological Ultrasound), in 2011 he became Vice-President, and since 2006 he has been a member of the Scientific Committee of SIURO (Italian Society of Oncological Urology). Since January 2016, he has been a full member of the Board of ESUI (European Society of Urological Imaging).

Latest publications

Dynamic Gadolinium enhanced magnetic resonance imaging in staging of superficial bladder cancer

J Urol 155: 1594-1599, 1996.

Scattoni V, Da Pozzo L, Colombo R, Nava L, Rigatti P, De Cobelli F, Vanzulli A, Del Maschio A

Percent of free serum prostate-specific antigen and hystological findings in patients undergoing open prostatectomy for benign prostatic hyperplasia

Eur Urol 36:621-630, 1999

Scattoni V, Raber M, Montorsi F, Da Pozzo L, Brausi M, Calori G, Freschi M, Rigatti P

Prostatic transrectal ultrasound (TRUS) guided biopsy schemes and TRUS prostatic lesion-guided biopsies

Eur Urol Suppl 1(6): 28-34, 2002.

Scattoni V, Zlotta AR, Nava L, Roscigno M, Montorsi F, Rigatti P

Biopsy of the vesico-urethral anastomosis after radical prostatectomy: when and how

Eur Urol Suppl 1(6): 89-95, 2002.

Scattoni V, Roscigno M, Raber M, Consonni P, Da Pozzo L, Rigatti P

Multiple vesico-urethral biopsies following a radical prostatectomy: the predictive roles of TRUS, DRE, PSA and the pathological stage

Eur Urol 44:407-414, 2003.

Scattoni V, Roscigno M, Raber M, Montorsi F, Da Pozzo L, Guazzoni G, Freschi M, Rigatti P

Diagnosis of local recurrence after radical prostatectomy.

BJU Int 93(5), 680-688, 2004

Scattoni V, Montorsi F, Picchio M, Roscigno M, Salonia A, Rigatti P, F. Fazio

Predictors of prostate cancer after initial diagnosis of atypical small acinar proliferation at 10 to 12 core biopsies.

Urology 66: 1043-1047, 2005.

Scattoni V, Roscigno M, Freschi M, Briganti A, Fantini GV, Bertini R, Salonia A, Montorsi F, Rigatti P

Pathological changes of high-grade prostatic intraepithelial neoplasia and prostate cancer after monotherapy with bicalutamide 150 mg

BJU Int. Jul;98(1):54-8. 2006

Scattoni V, Montironi R, Mazzucchelli R, Freschi M, Nava L, Losa A, Terrone C, Scarpa RM, Montorsi F, Pappagallo G, Rigatti P.

Validation of a nomogram predicting the probability of lymph node invasion among patients undergoing radical prostatectomy and an extended pelvic lymphadenectomy

Eur Urol; 49(6):1019-26, 2006.

Briganti A, Chun FK, Salonia A, Zanni G, Scattoni V, Valiquette L, Rigatti P,Montorsi F, Karakiewicz PI

Detection of lymph-node metastases with integrated [11C]choline PET/CT in patients with PSA failure after radical retropubic prostatectomy: results confirmed by open pelvic-retroperitoneal lymphadenectomy

Eur Urol; 52(2):423- 9, 2007

Scattoni V, Picchio M, Suardi N, Messa C, Freschi M, Roscigno M, Da Pozzo L, Bocciardi A, Rigatti P, Fazio F

Extended and saturation prostatic biopsy in the diagnosis and characterisation of prostate cancer: a critical analysis of the literature

Eur Urol; 52(5):1309-22, 2007

Scattoni V, Zlotta A, Montironi R, Schulman C, Rigatti P, Montorsi F

Initial extended transrectal prostate biopsy--are more prostate cancers detected with 18 cores than with 12 cores?

J Urol; 179(4):1327-31, 2008.

Scattoni V, Roscigno M, Raber M, Dehò F, Maga T, Zanoni M, Riva M, Sangalli M, Nava L, Mazzoccoli B, Freschi M, Guazzoni G, Rigatti P, Montorsi F.

Percent free prostate-specific antigen (PSA) is an accurate predictor of prostate cancer risk in men with serum PSA 2.5 ng/mL and lower.

Cancer; 113(10):2695-703, 2008

Walz J, Haese A, Scattoni V, Steuber T, Chun FK, Briganti A, Montorsi F, Graefen M, Huland H, Karakiewicz PI

Biopsy schemes with the fewest cores for detecting 95% of the prostate cancers detected by a 24-core biopsy.

Eur Urol; 57(1):1-8, 2010

Scattoni V, Raber M, Abdollah F, Roscigno M, Dehò F, Angiolilli D, Maccagnano C, Gallina A, Capitanio U, Freschi M, Doglioni C, Rigatti P, Montorsi F

Is extended and saturation biopsy necessary?

Int J Urol; 17(5):432-47, 2010

Scattoni V, Maccagnano C, Zanni G, Angiolilli D, Raber M, Roscigno M, Rigatti P, Montorsi F

Do you need an appointment?

Request an appointment